DANIELLE MCDONOUGH: Open Payments
NPI 1770954836 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 51 payments from 17 companies in 2025. Trend: 2023 $1,332 · 2024 $1,310 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $170 |
| AstraZeneca Pharmaceuticals LP | 7 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $91 |
| Novo Nordisk Inc | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| ABIOMED | 3 | $56 |
| Amgen Inc. | 3 | $50 |
Products named: LEQVIO, FARXIGA, Kerendia, CAMZYOS, Wegovy, JARDIANCE, VERQUVO, NEXLETOL.
Industry payments across FL — which companies pay providers there.
